These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2874227)

  • 1. Synthesis and beta-adrenergic receptor blocking potency of 1-(substituted amino)-3-(4-indolyloxy)propan-2-ols.
    Tejani-Butt SM; Brunswick DJ
    J Med Chem; 1986 Aug; 29(8):1524-7. PubMed ID: 2874227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural derivatives of pindolol: relationship between in vivo and in vitro potencies for their interaction with central beta-adrenergic receptors.
    Tejani-Butt SM; Brunswick DJ
    Life Sci; 1987 Aug; 41(8):995-1002. PubMed ID: 3039280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of beta adrenergic agonists and antagonists with brain beta adrenergic receptors in vivo.
    Conway PG; Tejani-Butt S; Brunswick DJ
    J Pharmacol Exp Ther; 1987 Jun; 241(3):755-62. PubMed ID: 2885407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labeling in vivo of beta adrenergic receptors in the central nervous system of the rat after administration of [125I] iodopindolol.
    Tondo L; Conway PG; Brunswick DJ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):1-9. PubMed ID: 2995641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (-)-[125I]-iodopindolol, a new highly selective radioiodinated beta-adrenergic receptor antagonist: measurement of beta-receptors on intact rat astrocytoma cells.
    Barovsky K; Brooker G
    J Cyclic Nucleotide Res; 1980; 6(4):297-307. PubMed ID: 6110683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of putatively irreversible antagonists with beta 1- and beta 2-adrenergic receptors.
    Minneman KP; Mowry CB
    Biochem Pharmacol; 1986 Mar; 35(5):857-64. PubMed ID: 2869757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential reduction of binding of 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments.
    Ordway GA; Gambarana C; Tejani-Butt SM; Areso P; Hauptmann M; Frazer A
    J Pharmacol Exp Ther; 1991 May; 257(2):681-90. PubMed ID: 1674532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [125I]iodopindolol: a new beta adrenergic receptor probe.
    Ezrailson EG; Garber AJ; Munson PJ; Swartz TL; Birnbaumer L; Entman ML
    J Cyclic Nucleotide Res; 1981; 7(1):13-26. PubMed ID: 6265511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a homogeneous class of beta 2-adrenoceptors in human platelets by (-)-125I-iodopindolol binding.
    Wang XL; Brodde OE
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(5):439-50. PubMed ID: 2866204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative autoradiography of central beta adrenoceptor subtypes: comparison of the effects of chronic treatment with desipramine or centrally administered l-isoproterenol.
    Ordway GA; Gambarana C; Frazer A
    J Pharmacol Exp Ther; 1988 Oct; 247(1):379-89. PubMed ID: 2845059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Adrenergic receptors in rat brain.
    Sporn JR; Molinoff PB
    J Cyclic Nucleotide Res; 1976; 2(3):149-61. PubMed ID: 6494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopharmacological consequences of activation of beta adrenergic receptors by SOM-1122.
    O'Donnell JM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):38-46. PubMed ID: 2899168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photoaffinity labeling of the beta-adrenergic receptor in synaptic membranes of rat cerebral cortex and cerebellum.
    Lautens LL; Ruoho AE
    Brain Res; 1987 Nov; 426(2):401-6. PubMed ID: 2825919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of radiolabeled antagonists for imaging of beta-adrenoceptors in the brain with PET.
    Doze P; Elsinga PH; Maas B; Van Waarde A; Wegman T; Vaalburg W
    Neurochem Int; 2002 Feb; 40(2):145-55. PubMed ID: 11738481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of beta-adrenergic receptors in rat brain and pituitary using a new high-affinity ligand, [125I]iodocyanopindolol.
    Petrovic SL; McDonald JK; Snyder GD; McCann SM
    Brain Res; 1983 Feb; 261(2):249-59. PubMed ID: 6299466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of cyanopindolol analogues active at the beta 3-adrenoceptor in rat ileum.
    Hoey AJ; Jackson CM; Pegg GG; Sillence MN
    Br J Pharmacol; 1996 Oct; 119(3):564-8. PubMed ID: 8894179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-independent sequestration of beta-adrenergic ligands by alveolar type II cells.
    Fabisiak JP; Rannels SR; Vesell ES; Rannels DE
    Am J Physiol; 1986 Jun; 250(6 Pt 1):C871-9. PubMed ID: 3013016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogeny of beta 1- and beta 2-adrenergic receptors in rat cerebellum and cerebral cortex.
    Pittman RN; Minneman KP; Molinoff PB
    Brain Res; 1980 Apr; 188(2):357-68. PubMed ID: 6245756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sensitive equilibrium binding assay for soluble beta-adrenergic receptors.
    Witkin KM; Harden TK
    J Cyclic Nucleotide Res; 1981; 7(4):235-46. PubMed ID: 6278007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of beta-1 and beta-2 adrenergic receptors in the human heart: effects of treatment with receptor antagonists or calcium entry blockers.
    Hedberg A; Kempf F; Josephson ME; Molinoff PB
    J Pharmacol Exp Ther; 1985 Sep; 234(3):561-8. PubMed ID: 2863366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.